Research Article
Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract
Table 2
Obesity indicators and impact of CFE.
| | Weight in grams | Mean values | Browne-Forsyth | Sig. | | Untreated control | Cafeteria | 25 mg CFE | 50 mg CFE | 100 mg CFE | | | | (SEM) | (SEM) | (SEM) | (SEM) | (SEM) | | |
| | Serum lipids | | | | | | | | | Cholesterol | 74.78 (±0.46) | 94.16 (±0.48) | 89.20(±1.61) | 82.86 (±1.73) | 76.30 (±1.29) | 44.63 | 0.0001 | | Triglyceride | 72.6 (±0.98) | 150.9 (±1.61) | 117.3(±0.93) | 108.36 (±1.51) | 95.9 (±0.75) | 568.74 | 0.0001 | | LDL | 18.89 (±1.02) | 36.5 (±1.40) | 35.54(±1.02) | 20.37 (±0.79) | 14.28 (±1.08) | 88.8 | 0.0001 | | HDL | 42.8 (±1.92) | 25.62 (±1.78) | 25.5(±2.3) | 40.9 (±0.64) | 43.0 (±0.74) | 32.15 | 0.0001 | | VLDL | 13.15 (±0.60) | 33.02 (±1.19) | 23.57(±0.8) | 21.62 (±0.93) | 19.62 (±1.1) | 58.01 | 0.0001 | | Serum leptin | 1.65 (±0.17) | 13.9 (±0.68) | 3.40 (±0.11) | 1.92 (±0.20) | 1.63 (±0.27) | 1237.7 | 0.0001 | | in each group | 6 | 6 | 6 | 6 | 6 | | |
|
|
